Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
In NSTEACS, is an early invasive strategy (within 24 hours) useful for all the patients and not only for those at high risk ?Yes 47%No 53 %
The recent NSTEMI guidelines (Hamm et al., Eur Heart J 2011) ask for a quick diagnostic angiography in all patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS). This is a clear modification compared to the myocardial revascularization guidelines (Wijns et al. Eur Heart J 2010) and the PCI-guidelines published before (Silber et al. Eur Heart J 2005), which asked for 48 hours and 72 hours, respectively. Particularly, it is essential to stay within 24 hours of diagnosis in patients with high-risk NSTE-AC (ST-segment deviation, rhythm disturbances, ongoing symptoms, increase in troponin, hemodynamical deterioriation). If the organization of the diagnostic angiogram +/- percutaneous intervention If necessary) is not possible within 24 hours in moderate-to-lower risk patients with NSTE-ACS due to the lack of open catheter laboratories, 48 hours might be acceptable but should not be the primary goal
This findings of the poll are surprising because the randomised trial evidence and the guidelines specifically support early intervention in higher- risk patients
© 2017 European Society of Cardiology. All rights reserved